A Battle on Two Fronts: Coronavirus and Addiction

BETHESDA, MD—Researchers at the National Institute on Drug Abuse (NIDA) had been fighting one daunting national health crisis already when the COVID-19 pandemic launched its attack on the U.S. Now, these federal scientists face the dual challenges of reducing the...

Benzodiazepines Prescribed Long-Term for COPD/PTSD

SEATTLE — Symptoms of insomnia and anxiety are common among patients with chronic obstructive pulmonary disease, and that is especially the case among patients with comorbid mental health disorders such as posttraumatic stress disorder, according to a new study.

MHS Pharmacies Prescribed 6,200 Naloxone Kits Under New Directive

MHS Pharmacies Prescribed 6,200 Naloxone Kits Under New Directive

FALLS CHURCH, VA — In June 2018, Defense Health Agency Director Raquel Bono, MD, directed all MHS pharmacies to dispense the opioid reversal agent naloxone to eligible beneficiaries and those who request it without requiring a prescription. Since then, MHS pharmacists have provided more than 6,200 kits.